[HTML][HTML] Kidney involvement in COVID-19 and rationale for extracorporeal therapies
The prevalence of direct kidney involvement in novel coronavirus disease (COVID-19) is
low, but such involvement is a marker of multiple organ dysfunction and severe disease …
low, but such involvement is a marker of multiple organ dysfunction and severe disease …
[PDF][PDF] Kidney involvement in COVID-19 and rationale for extracorporeal therapies
C Ronco, T Reis - jafroninternational.com
The prevalence of direct kidney involvement in novel coronavirus disease (COVID-19) is
low, but such involvement is a marker of multiple organ dysfunction and severe disease …
low, but such involvement is a marker of multiple organ dysfunction and severe disease …
[PDF][PDF] Kidney involvement in COVID-19 and rationale for extracorporeal therapies
C Ronco, T Reis - medicinadimed.unipd.it
The prevalence of direct kidney involvement in novel coronavirus disease (COVID-19) is
low, but such involvement is a marker of multiple organ dysfunction and severe disease …
low, but such involvement is a marker of multiple organ dysfunction and severe disease …
[PDF][PDF] Kidney involvement in COVID-19 and rationale for extracorporeal therapies
C Ronco, T Reis - cgmh.org.tw
The prevalence of direct kidney involvement in novel coronavirus disease (COVID-19) is
low, but such involvement is a marker of multiple organ dysfunction and severe disease …
low, but such involvement is a marker of multiple organ dysfunction and severe disease …
[PDF][PDF] Kidney involvement in COVID-19 and rationale for extracorporeal therapies
C Ronco, T Reis - researchgate.net
The prevalence of direct kidney involvement in novel coronavirus disease (COVID-19) is
low, but such involvement is a marker of multiple organ dysfunction and severe disease …
low, but such involvement is a marker of multiple organ dysfunction and severe disease …
Kidney involvement in COVID-19 and rationale for extracorporeal therapies
C Ronco, T Reis - Nature Reviews Nephrology, 2020 - go.gale.com
On 11 March 2020, the World Health Organization declared novel coronavirus disease
(COVID-19) to be a global pandemic. Among patients who have tested positive for COVID …
(COVID-19) to be a global pandemic. Among patients who have tested positive for COVID …
Kidney involvement in COVID-19 and rationale for extracorporeal therapies
C Ronco, T Reis - Nature reviews. Nephrology, 2020 - pubmed.ncbi.nlm.nih.gov
The prevalence of direct kidney involvement in novel coronavirus disease (COVID-19) is
low, but such involvement is a marker of multiple organ dysfunction and severe disease …
low, but such involvement is a marker of multiple organ dysfunction and severe disease …
[HTML][HTML] Kidney involvement in COVID-19 and rationale for extracorporeal therapies
C Ronco, T Reis - Nature Reviews. Nephrology, 2020 - ncbi.nlm.nih.gov
The prevalence of direct kidney involvement in novel coronavirus disease (COVID-19) is
low, but such involvement is a marker of multiple organ dysfunction and severe disease …
low, but such involvement is a marker of multiple organ dysfunction and severe disease …
[PDF][PDF] Kidney involvement in COVID-19 and rationale for extracorporeal therapies
C Ronco, T Reis - jvsmedicscorner.com
The prevalence of direct kidney involvement in novel coronavirus disease (COVID-19) is
low, but such involvement is a marker of multiple organ dysfunction and severe disease …
low, but such involvement is a marker of multiple organ dysfunction and severe disease …
Kidney involvement in COVID-19 and rationale for extracorporeal therapies.
C Ronco, T Reis - Nature reviews. Nephrology, 2020 - europepmc.org
The prevalence of direct kidney involvement in novel coronavirus disease (COVID-19) is
low, but such involvement is a marker of multiple organ dysfunction and severe disease …
low, but such involvement is a marker of multiple organ dysfunction and severe disease …